| 2024-12-31 |
复牌提示：
2024-12-30 16:05:06 停牌，复牌日期 2024-12-30 17:05:00
|
| 2024-11-19 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.63美元,归母净利润-7176.3万美元,同比去年增长38.16%
|
| 2024-11-19 |
财报披露：
美东时间 2024-11-19 盘前发布财报
|
| 2024-11-01 |
详情>>
股本变动：
变动后总股本301.99万股
变动原因 ▼▲
- 原因：
- a reverse stock split of Danimer’s Class A common stock, par value $0.0001 per share,at a ratio of 1-for-40
|
| 2024-11-01 |
详情>>
拆分方案：
每40.0000合并分成1.0000股
|
| 2024-09-23 |
股东大会：
将于2024-10-23召开股东大会
会议内容 ▼▲
- 1.To approve an amendment and restatement of Danimer’s Fifth Amended and Restated Certificate of Incorporation (the “Existing Certificate of Incorporation”) to effect, at the discretion of the Board of Directors, a reverse stock split of all outstanding shares of the Company’s Class A common stock, par value $0.0001 per share (“Common Stock”), into a lesser number of shares of Common Stock at a ratio in a range of 1-for-20 to 1-for-40 (“Range”), with the ratio within such Range to be determined at the discretion of the Board of Directors without further approval or authorization of our stockholders and included in a public announcement (“Reverse Stock Split”) and such amended and restated certificate of incorporation (“Proposal 1” or “Reverse Stock Split Proposal”).
2.To transact such other business as may properly come before the Meeting, including to consider any procedural matters incident to the conduct of the Meeting, such as a postponement in order to solicit additional proxies to vote in favor of the matters presented at the Meeting.
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.45美元,归母净利润-4992.4万美元,同比去年增长34.21%
|
| 2024-05-30 |
股东大会：
将于2024-07-09召开股东大会
会议内容 ▼▲
- 1.To elect the eleven nominees named in the accompanying Proxy Statement to serve on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024;
3.To approve an amendment and restatement of the Company’s Fourth Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company’s Class A common stock, par value $0.0001 per share;
4.To approve an amendment to the Danimer Scientific, Inc. 2020 Long Term Incentive Plan to increase the number of shares of the Company’s Class A common stock, par value $0.0001 per share, available for issuance under the plan;
5.To transact such other business as may properly come before the Meeting, including to consider any procedural matters incident to the conduct of the Meeting, such as a postponement in order to solicit additional proxies to vote in favor of the matters presented at the Meeting.
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.26美元,归母净利润-2726.3万美元,同比去年增长25.59%
|
| 2024-03-29 |
详情>>
业绩披露：
2023年年报每股收益-1.52美元,归母净利润-1.55亿美元,同比去年增长13.51%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.14美元,归母净利润-1.16亿美元,同比去年增长23.51%
|
| 2023-08-08 |
详情>>
业绩披露：
2023年中报每股收益-0.74美元,归母净利润-7588万美元,同比去年增长-33.52%
|
| 2023-05-10 |
详情>>
业绩披露：
2023年一季报每股收益-0.36美元,归母净利润-3663.9万美元,同比去年增长-38.86%
|
| 2023-04-17 |
股东大会：
将于2023-06-01召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees named in the accompanying Proxy Statement to serve on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified (Proposal 1);
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 (Proposal 2);
3.To transact such other business as may properly come before the Meeting, including to consider any procedural matters incident to the conduct of the Meeting, such as the postponement in order to solicit additional proxies to vote in favor of the matters presented at the Meeting.
|
| 2023-03-28 |
详情>>
业绩披露：
2022年年报每股收益-1.78美元,归母净利润-1.8亿美元,同比去年增长-199.06%
|
| 2022-11-08 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.5美元,归母净利润-1.52亿美元,同比去年增长-218.3%
|
| 2022-08-09 |
详情>>
业绩披露：
2022年中报每股收益-0.56美元,归母净利润-5683.1万美元,同比去年增长-2.42%
|
| 2022-06-30 |
股东大会：
将于2022-08-11召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees named in the accompanying Proxy Statement to serve on the Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified (Proposal 1);
2.To approve an advisory resolution on executive compensation (Proposal 2);
3.To conduct an advisory vote on the frequency of future advisory votes on executive compensation (Proposal 3);
4.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022 (Proposal 4);
5.To transact such other business as may properly come before the Meeting, including to consider any procedural matters incident to the conduct of the Meeting, such as the postponement of the Meeting in order to solicit additional proxies to vote in favor of the matters presented at the Meeting.
|
| 2021-11-12 |
股东大会：
将于2021-12-15召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees named in the accompanying Proxy Statement to serve on the Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified (Proposal 1);
2.To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2021 (Proposal 2);
3.To transact such other business as may properly come before the Meeting, including to consider any procedural matters incident to the conduct of the Meeting, such as the postponement of the Meeting in order to solicit additional proxies to vote in favor of the matters presented at the Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-12-29 |
详情>>
内部人交易：
Live Oak Sponsor Partners, LLC等共交易9笔
|
| 2020-12-16 |
股东大会：
将于2020-12-28召开股东大会
会议内容 ▼▲
- 1.The “Business Combination Proposal”-to consider and vote upon a proposal to approve and adopt the merger agreement, dated as of October 3, 2020 (as may be amended from time to time, the “Merger Agreement”), by and among Live Oak, Green Merger Corp., a Georgia corporation and a wholly-owned subsidiary of Live Oak (“Merger Sub”), Meredian Holdings Group, Inc., doing business as Danimer Scientific, a Georgia corporation (the “Danimer”), Live Oak Sponsor Partners, LLC (the “Sponsor”), as representative for Live Oak, for certain purposes described in the Merger Agreement (the “Live Oak Representative”), and John A. Dowdy, Jr., as representative of the shareholders of Danimer for certain purposes described in the Merger Agreement (the “Shareholder Representative”), and the transactions contemplated thereby, pursuant to which Merger Sub will merge with and into Danimer, with Danimer surviving the merger and becoming a wholly-owned direct subsidiary of Live Oak (collectively with the other transactions described in the Merger Agreement, the “Business Combination”);
2.The “Charter Amendment Proposal”-to consider and vote upon a proposal to approve the amendment of Live Oak’s Third Amended and Restated Certificate of Incorporation to change Live Oak’s name to “Danimer Scientific, Inc.,” increase the authorized shares of our common stock and preferred stock, approve choice of forum provisions, remove the provisions providing for a classified board of directors, remove the provision renouncing the corporate opportunity doctrine, and approve all other changes including eliminating certain provisions related to our Initial Business Combination (as defined in this proxy statement/prospectus) that will no longer be relevant following the closing of the Business Combination (the “Closing”);
3.The “Election of Directors Proposal”-to consider and vote upon a proposal to elect, effective at the Closing, eight directors to serve on our board of directors until the next annual meeting of stockholders, and until their respective successors are duly elected and qualified.
4.The “NYSE Proposal”-to consider and vote upon a proposal to approve, for purposes of complying with the applicable provisions of Section 312.03 of the NYSE’s (as defined below) Listed Company Manual, (a) the issuance of more than 20% of Live Oak’s Common Stock in connection with the Business Combination, including, without limitation, to the investors in the PIPE (as defined below) and (b) the issuance of shares of Live Oak’s Common Stock to a Related Party (as defined in Section 312.03 of the NYSE’s Listed Company Manual) in connection with the Business Combination.
5.The “Equity Incentive Plan Proposal”-to consider and vote upon a proposal to approve and adopt the equity incentive award plan established to be effective after the Closing of the Business Combination.
6.The “Employee Stock Purchase Plan Proposal”-to consider and vote upon a proposal approve and adopt the employee stock purchase plan established to be effective after the Closing of the Business Combination.
7.The “Adjournment Proposal”-to consider and vote upon a proposal to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve one or more proposals presented to stockholders for vote.
|